news Hymecromone can suppress neuroinflammation in astrocytes, study shows 1 March 2021 | By Victoria Rees (Drug Target Review) Researchers have found that the spasmolytic drug hymecromone can suppress astrocyte inflammatory responses, meaning it could be used to combat Alzheimer's disease.